C CANOPY GROWTH CORP
| Market Cap | $443.07M |
| P/E Ratio | — |
| Forward P/E | -14.46 |
| Dividend Yield | — |
| Beta | 2.34 |
| 52W Range | $0.77 - $2.38 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 9 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| BAYERN JOSEPH | Sale | 2,658 | $0.93 | $2.47K | 31 Mar 2026 | 31 Mar 2026 |
| Yanofsky Theresa | Sale | 10,373 | $0.93 | $9.65K | 31 Mar 2026 | 31 Mar 2026 |
| ATKINS M SHAN | Sale | 2,074 | $0.93 | $1.93K | 31 Mar 2026 | 31 Mar 2026 |
| Lazzarato David Angelo | Sale | 15,624 | $0.93 | $14.53K | 31 Mar 2026 | 31 Mar 2026 |
| Mongeau LucChief Executive Officer | Sale | 9,376 | $1.06 | $9.95K | 11 Feb 2026 | 12 Feb 2026 |
| Lazzarato David Angelo | Sale | 15,715 | $1.13 | $17.76K | 31 Dec 2025 | 02 Jan 2026 |
| Yanofsky Theresa | Sale | 10,434 | $1.13 | $11.79K | 31 Dec 2025 | 02 Jan 2026 |
| Theresa YanofskyDirector | Sale | 10,434 | $1.13 | $11.79K | 31 Dec 2025 | 02 Jan 2026 |
| David Angelo LazzaratoDirector | Sale | 15,715 | $1.13 | $17.76K | 31 Dec 2025 | 02 Jan 2026 |
Frequently Asked Questions
What is CGC stock price today?
CANOPY GROWTH CORP (CGC) is currently trading at $1.07. The stock has a 52-week range of $0.77 to $2.38 and a market capitalization of $443.07M.
Is CGC a good stock to buy in 2026?
CANOPY GROWTH CORP has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of -4.5%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling CGC stock?
There have been 9 insider transactions for CGC in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has CGC stock performed over the past year?
CANOPY GROWTH CORP (CGC) has returned -4.5% over the past 12 months. The stock traded between $0.77 and $2.38 during this period, and is currently at $1.07.
Which hedge funds own CGC (CANOPY GROWTH CORP)?
0 tracked hedge funds currently hold CGC in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is CGC's market cap and valuation?
CANOPY GROWTH CORP (CGC) has a market capitalization of $443.07M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is CGC's revenue and profitability?
CANOPY GROWTH CORP reported revenue of $278.39M with net income of N/A and a profit margin of N/A. The stock has a beta of 2.34.
What sector is CGC in and who are its biggest institutional holders?
CANOPY GROWTH CORP (CGC) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.